Literature DB >> 1090175

Calcium metabolism in pregnancy: a review.

R M Pitkin.   

Abstract

Calcium metabolism in pregnancy is a complex process involving calcium, phosphorus, vitamin D, parathyroid hormone (PTH), and calcitonin (CT). Calcium absorption is enhanced in pregnancy, and increased storage in the maternal skeleton probably occurs as well. Adequate amounts are provided by the current Recommended Dietary Allowance of 1,200 mg. daily which can be met readily by natural foods, specifically milk. If supplemental calcium is given, a nonphosphate salt is probably advisable, since some evidence suggests that excessive phosphate intake may be related to leg cramps in pregnancy. Vitamin D is necessary for optimal calcium utilization in pregnancy, although the possibility of fetal toxicity with overdosage has been suggested. From a review of available information with respect to maternal-perinatal calcium interrelationships, I propose the following hypothesis: While total maternal serum calcium declines during pregnancy because of the physiologic hypoalbuminemia, the level of ionic calcium remains constant, in part, at least, because of increasing maternal PTH output. The placenta plays a primary role in fetal calcium metabolism by transporting calcium ions from the mother to the fetus against a concentration gradient. Relatively high fetal ionic calcium levels cause suppression of PTH and stimulation of CT in the fetus, facilitating growth of the fetal skeleton. With sudden loss of the placental source of calcium at birth, the newborn infant becomes functionally hypoparathyroid and/or hypercalcitonemic, and the serum calcium level declines until 3 to 4 days of life when PTH rises and CT falls with a resultant slight rise in calcium.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1090175     DOI: 10.1016/0002-9378(75)90481-0

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  18 in total

1.  Endochondral bone growth during early pregnancy compared with pseudopregnancy in rats.

Authors:  B M Bowman; S C Miller
Journal:  Endocrine       Date:  1997-04       Impact factor: 3.633

2.  Hypoparathyroidism in pregnancy.

Authors:  Krupa Hitesh Shah; Shashikala Bhat; Seema Shetty; Shashikiran Umakanth
Journal:  BMJ Case Rep       Date:  2015-07-15

3.  Primary hyperparathyroidism: changes on biochemical and hormonal profile related to pregnancy.

Authors:  J M Lopez; C B Fardella
Journal:  J Endocrinol Invest       Date:  1989-02       Impact factor: 4.256

4.  Normal reference ranges for biochemical substances relating to renal, hepatic, and bone function in fetal and maternal plasma throughout pregnancy.

Authors:  C F Moniz; K H Nicolaides; F J Bamforth; C H Rodeck
Journal:  J Clin Pathol       Date:  1985-04       Impact factor: 3.411

5.  Influence of pregnancy on immunoreactive parathyroid hormone levels.

Authors:  M E Gillette; K L Insogna; A M Lewis; D T Baran
Journal:  Calcif Tissue Int       Date:  1982-01       Impact factor: 4.333

6.  Calcium intake in the first five days of life in the low birthweight infant. Effects of calcium supplements.

Authors:  M Moya; E Doménech
Journal:  Arch Dis Child       Date:  1978-10       Impact factor: 3.791

7.  Calcium homeostasis in the first days of life in relation to feeding.

Authors:  F Bagnoli; S Bruchi; S Sardelli; G Buonocore; L Vispi; F Franchi; R Bracci
Journal:  Eur J Pediatr       Date:  1985-05       Impact factor: 3.183

8.  Cytochemical bioassay of parathyroid hormone in maternal and cord blood.

Authors:  J Allgrove; S Adami; R M Manning; J L O'Riordan
Journal:  Arch Dis Child       Date:  1985-02       Impact factor: 3.791

9.  Vitamin D metabolism during pregnancy and lactation in the rat.

Authors:  B P Halloran; E N Barthell; H F DeLuca
Journal:  Proc Natl Acad Sci U S A       Date:  1979-11       Impact factor: 11.205

10.  Increased serum calcitonin in pregnancy.

Authors:  O L Silva; P Titus-Dillon; K L Becker; R H Snider; C F Moore
Journal:  J Natl Med Assoc       Date:  1981       Impact factor: 1.798

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.